Stockreport

BioCardia Signs Exclusive Development Agreement With AstraZeneca

BioCardia, Inc.  (BCDA) 
PDF SAN CARLOS, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerat [Read more]